Literature DB >> 27807283

Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells.

Florian Weinberger1,2, Kaja Breckwoldt1,2, Simon Pecha2,3, Allen Kelly4,5, Birgit Geertz1,2, Jutta Starbatty1,2, Timur Yorgan6, Kai-Hung Cheng7, Katrin Lessmann1,2, Tomas Stolen4,5, Marielle Scherrer-Crosbie7, Godfrey Smith4,8, Hermann Reichenspurner2,3, Arne Hansen1,2, Thomas Eschenhagen9,2.   

Abstract

Myocardial injury results in a loss of contractile tissue mass that, in the absence of efficient regeneration, is essentially irreversible. Transplantation of human pluripotent stem cell-derived cardiomyocytes has beneficial but variable effects. We created human engineered heart tissue (hEHT) strips from human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and hiPSC-derived endothelial cells. The hEHTs were transplanted onto large defects (22% of the left ventricular wall, 35% decline in left ventricular function) of guinea pig hearts 7 days after cryoinjury, and the results were compared with those obtained with human endothelial cell patches (hEETs) or cell-free patches. Twenty-eight days after transplantation, the hearts repaired with hEHT strips exhibited, within the scar, human heart muscle grafts, which had remuscularized 12% of the infarct area. These grafts showed cardiomyocyte proliferation, vascularization, and evidence for electrical coupling to the intact heart tissue in a subset of engrafted hearts. hEHT strips improved left ventricular function by 31% compared to that before implantation, whereas the hEET or cell-free patches had no effect. Together, our study demonstrates that three-dimensional human heart muscle constructs can repair the injured heart.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2016        PMID: 27807283     DOI: 10.1126/scitranslmed.aaf8781

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  91 in total

Review 1.  Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.

Authors:  Shin Kadota; Yuji Shiba
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

Review 2.  Myocardial Tissue Engineering for Regenerative Applications.

Authors:  Buntaro Fujita; Wolfram-Hubertus Zimmermann
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

3.  Differentiation of cardiomyocytes and generation of human engineered heart tissue.

Authors:  Kaja Breckwoldt; David Letuffe-Brenière; Ingra Mannhardt; Thomas Schulze; Bärbel Ulmer; Tessa Werner; Anika Benzin; Birgit Klampe; Marina C Reinsch; Sandra Laufer; Aya Shibamiya; Maksymilian Prondzynski; Giulia Mearini; Dennis Schade; Sigrid Fuchs; Christiane Neuber; Elisabeth Krämer; Umber Saleem; Mirja L Schulze; Marita L Rodriguez; Thomas Eschenhagen; Arne Hansen
Journal:  Nat Protoc       Date:  2017-05-11       Impact factor: 13.491

4.  Laser-Etched Designs for Molding Hydrogel-Based Engineered Tissues.

Authors:  Fabiola Munarin; Nicholas J Kaiser; Tae Yun Kim; Bum-Rak Choi; Kareen L K Coulombe
Journal:  Tissue Eng Part C Methods       Date:  2017-05       Impact factor: 3.056

Review 5.  Remuscularization of the failing heart.

Authors:  Wolfram-Hubertus Zimmermann
Journal:  J Physiol       Date:  2017-04-25       Impact factor: 5.182

6.  Injectable Drug-Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction.

Authors:  Jun Fang; Jaekyung Koh; Qizhi Fang; Huiliang Qiu; Maani M Archang; Mohammad Mahdi Hasani-Sadrabadi; Hiromi Miwa; Xintong Zhong; Richard Sievers; Dong-Wei Gao; Randall Lee; Dino Di Carlo; Song Li
Journal:  Adv Funct Mater       Date:  2020-09-06       Impact factor: 18.808

7.  Biodegradable nanofibrous temperature-responsive gelling microspheres for heart regeneration.

Authors:  Chao Zhao; Shuo Tian; Qihai Liu; Kemao Xiu; Ienglam Lei; Zhong Wang; Peter X Ma
Journal:  Adv Funct Mater       Date:  2020-03-20       Impact factor: 18.808

8.  Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation.

Authors:  Christopher P Jackman; Asvin M Ganapathi; Huda Asfour; Ying Qian; Brian W Allen; Yanzhen Li; Nenad Bursac
Journal:  Biomaterials       Date:  2018-01-03       Impact factor: 12.479

Review 9.  Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.

Authors:  Angelos Oikonomopoulos; Tomoya Kitani; Joseph C Wu
Journal:  Mol Ther       Date:  2018-03-06       Impact factor: 11.454

10.  Engineered human myocardium with local release of angiogenic proteins improves vascularization and cardiac function in injured rat hearts.

Authors:  Fabiola Munarin; Rajeev J Kant; Cassady E Rupert; Amelia Khoo; Kareen L K Coulombe
Journal:  Biomaterials       Date:  2020-04-12       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.